Description

6-o-(2,3-Diamino-4-o-Methyl-2,3-Dideoxy-α-D-Xylopyranosyl)-4-o-(2,6-Diamino-2,4,6-Trideoxy-α-D-Xylo-Hexopyranosyl)-2-Deoxy-D-Streptamine is a structurally complex aminoglycoside derivative, representing a key intermediate in advanced pharmaceutical research and synthesis. This compound matters for its role in the development of novel antibiotics and as a critical building block for studying carbohydrate-protein interactions. It is primarily needed by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on anti-infective drug discovery and glycobiology.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of next-generation aminoglycoside antibiotics and related therapeutic agents.
• Biochemical Research: Used as a standard or probe in glycobiology studies to investigate enzyme mechanisms and carbohydrate recognition.
• Antibiotic Development: Acts as a core scaffold for structural modification to develop new antimicrobial compounds with improved efficacy and reduced toxicity.
• Academic Research: Employed in university and institutional labs for fundamental research on antibiotic resistance and mode of action.
• Fine Chemical Synthesis: Utilized as a specialized building block for the custom synthesis of complex oligosaccharides and glycoconjugates.

Basic Information

Item	Details
Product Name	6-o-(2,3-Diamino-4-o-Methyl-2,3-Dideoxy-α-D-Xylopyranosyl)-4-o-(2,6-Diamino-2,4,6-Trideoxy-α-D-Xylo-Hexopyranosyl)-2-Deoxy-D-Streptamine
CAS No.	56276-26-7
Molecular Formula	C19H37N7O9
Molecular Weight	507.54 g/mol
Synonyms	2-Deoxy-6-O-[2,3-diamino-4-O-methyl-2,3-dideoxy-α-D-xylopyranosyl]-4-O-[2,6-diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl]-D-streptamine; 6-O-(2,3-Diamino-4-O-methyl-2,3-dideoxy-α-D-xylopyranosyl)-4-O-(2,6-diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl)-2-deoxy-D-streptamine; 4-O-(2,6-Diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl)-6-O-(2,3-diamino-4-O-methyl-2,3-dideoxy-α-D-xylopyranosyl)-2-deoxystreptamine; Aminoglycoside Derivative 56276-26-7; Antibiotic Intermediate 56276-26-7; CAS 56276-26-7
EINECS	Contact for details

Quality Control

Our production of this high-purity biochemical adheres to strict quality management systems. Each batch undergoes comprehensive analytical characterization, including HPLC for purity and structural confirmation via spectroscopic methods. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided to ensure traceability and compliance with research-grade specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a desiccated environment to prevent degradation. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 1.0%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.